Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Classification of progressive systemic scleroderma].

H Holzmann, S Sollberg, P Altmeyer

    Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
    |May 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences.

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2020
    Same author

    Reduced seroprevalence against vaccine preventable diseases (VPDs) in adult patients with cancer: necessity of routine vaccination as part of the therapeutic concept.

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same author

    Letter: retreatment of patients with chronic hepatitis C who have failed interferon-free combination therapy with direct acting anti-virals.

    Alimentary pharmacology & therapeutics·2016
    Same author

    Nonparametric identification and maximum likelihood estimation for hidden Markov models.

    Biometrika·2016
    Same author

    Emergence of tick-borne encephalitis in new endemic areas in Austria: 42 years of surveillance.

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2015
    Same author

    Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral.

    Alimentary pharmacology & therapeutics·2013
    Same journal

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
    Same journal

    [Viral infections of the skin].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
    Same journal

    [Viral exanthems in children].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
    Same journal

    [Erratum to: Digital health applications and data protection].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
    Same journal

    [Virus-induced exanthems in returning travellers].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
    Same journal

    [Venous ulcus cruris-Surgical treatment].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
    See all related articles

    A novel classification for progressive systemic scleroderma (PSS) is introduced, incorporating rare forms and pathogenetic factors like immunogenetics. This updated system distinguishes between inflammatory and non-inflammatory subtypes for improved PSS diagnosis.

    Area of Science:

    • Rheumatology
    • Immunology
    • Dermatology

    Context:

    • Progressive systemic scleroderma (PSS) presents diverse clinical manifestations.
    • Existing classifications may not fully encompass all PSS subtypes or pathogenetic nuances.
    • Understanding PSS heterogeneity is crucial for effective patient management.

    Purpose:

    • To introduce a new, comprehensive classification system for progressive systemic scleroderma (PSS).
    • To integrate pathogenetic factors, including immunogenetic criteria, into PSS classification.
    • To differentiate between inflammatory and non-inflammatory subtypes of PSS.

    Summary:

    • The proposed classification expands beyond typical PSS forms to include rarer manifestations.
    • It incorporates immunological phenomena and distinguishes between non-inflammatory and inflammatory subtypes.

    Related Experiment Videos

  • Etiological, specifically immunogenetic, criteria are considered for the first time in PSS classification.
  • This classification framework is designed for future refinement and expansion.

    • Impact:

    • Facilitates more precise diagnosis and subtyping of progressive systemic scleroderma.
    • Provides a foundation for targeted research into PSS pathogenesis and immunogenetics.
    • Enables better understanding of disease heterogeneity, potentially leading to personalized treatment strategies.